NIQAX
Price
$15.11
Change
-$0.02 (-0.13%)
Updated
Oct 6 closing price
Net Assets
1.13B
REREX
Price
$63.86
Change
-$0.08 (-0.13%)
Updated
Oct 6 closing price
Net Assets
138.77B
Interact to see
Advertisement

NIQAX vs REREX

Header iconNIQAX vs REREX Comparison
Open Charts NIQAX vs REREXBanner chart's image
Neuberger Berman International Eq A
Price$15.11
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets1.13B
American Funds EUPAC R4
Price$63.86
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets138.77B
NIQAX vs REREX Comparison Chart in %
View a ticker or compare two or three
VS
NIQAX vs. REREX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIQAX is a StrongBuy and REREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REREX has more cash in the bank: 139B vs. NIQAX (1.13B). NIQAX pays higher dividends than REREX: NIQAX (1.17) vs REREX (0.68). NIQAX was incepted earlier than REREX: NIQAX (13 years) vs REREX (23 years). NIQAX (1.45) is less costly to investors than REREX (0.82). NIQAX is a more actively managed with annual turnover of: 64.00 vs. REREX (35.00). REREX has a lower initial minimum investment than NIQAX: REREX (250) vs NIQAX (1000). REREX annual gain was more profitable for investors over the last year : 10.81 vs. NIQAX (8.89). REREX return over 5 years is better than : 14.88 vs. NIQAX (12.28).
NIQAXREREXNIQAX / REREX
Total Expense Ratio1.260.82154%
Annual Report Gross Expense Ratio1.450.82177%
Fund Existence13 years23 years-
Gain YTD19.98422.08091%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B139B1%
Annual Yield % from dividends1.170.68173%
Returns for 1 year8.8910.8182%
Returns for 3 years51.4550.27102%
Returns for 5 years12.2814.8883%
Returns for 10 years49.2542.94115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
CRL174.95-2.38
-1.34%
Charles River Laboratories International
THM1.82-0.05
-2.67%
International Tower Hill Mines Ltd
TELA1.51-0.04
-2.88%
TELA Bio
VRDN20.83-0.82
-3.79%
Viridian Therapeutics